| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Adrenaline Impurity 74 |
Adrenaline Impurity 16 |
1894824-44-2 |
详细
|
| Erlotinib Impurity 143 |
厄洛替尼中间体 2 |
501684-22-6 |
详细
|
| Suramin Sodium |
苏拉明钠 |
129-46-4 |
详细
|
| Tartrazine Impurity 9 |
柠檬黄杂质9 |
104236-32-0 |
详细
|
| Esomeprazole Impurity 199 |
4-甲氧基间苯二胺 |
615-05-4 |
详细
|
| Ritlecitinib Impurity 66 |
利特昔替尼杂质66 |
2411407-23-1 |
详细
|
| Ritlecitinib Impurity 65 |
利特昔替尼杂质65 |
2411407-24-2 |
详细
|
| Ritlecitinib Impurity 31 |
利特昔替尼杂质31 |
2411407-19-5 |
详细
|
| Ezetimibe-13C6 |
依泽替米贝13C6 |
438624-68-1 |
详细
|
| Topiroxostat Impurity 80 |
托匹司他杂质80 |
2408929-54-2 |
详细
|
| Phenoxyethanol Impurity 3 |
|
1172919-42-4 |
详细
|
| Etoricoxib Impurity 88 |
4-甲砜基苯甲酸 |
4052-30-6 |
详细
|
| Ritlecitinib Impurity 82 |
|
2411407-26-4 |
详细
|
| Etomidate Impurity 60 |
依托咪酯 |
60197-34-4 |
详细
|
| Ritlecitinib Impurity 83 |
|
2411407-30-0 |
详细
|
| Ritlecitinib Impurity 88 |
|
2411407-68-4 |
详细
|
| Exemestane |
雄甾-4,9(11)-二烯-3,17-二酮 |
1035-69-4 |
详细
|
| Ritlecitinib Impurity 79 |
|
2411407-38-8 |
详细
|
| Ritlecitinib Impurity 80 |
|
2411407-33-3 |
详细
|
| Ritlecitinib Impurity 69 |
利特昔替尼杂质69 |
2411407-09-3 |
详细
|
| Ritlecitinib Impurity 72 |
利特昔替尼杂质72 |
2411407-28-6 |
详细
|
| Ritlecitinib Impurity 77 |
利特昔替尼杂质77 |
2411407-40-2 |
详细
|
| Prilocaine Impurity 44 |
rac-trans-2,5-Dimethyl-3-(2-methylphenyl)-1-propylimidazolini-4-one Hydrochloride |
677029-53-7 |
详细
|
| Vilanterol Impurity 76 |
3,4-二羟基苯乙醇醋酸 |
69039-02-7 |
详细
|
| Vilanterol Impurity 77 |
高香草醇 |
2380-78-1 |
详细
|
| Vilanterol Impurity 78 |
5-(2-羟乙基)-2-甲氧基苯酚 |
50602-41-0 |
详细
|
| Ritlecitinib Impurity 68 |
利特昔替尼杂质68 |
2411407-60-6 |
详细
|
| Ritlecitinib Impurity 87 |
|
2411407-69-5 |
详细
|
| Ritlecitinib Impurity 85 |
|
2923969-55-3 |
详细
|
| Ritlecitinib Impurity 84 |
|
2411407-29-7 |
详细
|
| Sulfadimethoxine Impurity 10 |
2-氨基苯磺酸 |
88-21-1 |
详细
|
| Unii-yht75V2nae |
3,7-二甲基- 2,6,8-三羟基嘌呤 |
13087-49-5 |
详细
|
| Dimidium bromide |
溴化底米鎓 |
518-67-2 |
详细
|
| Proline Impurity 18 |
N-BOC-2-甲基-L-脯氨酸 |
103336-06-7 |
详细
|
| Fosfomycin Calcium Salt |
磷霉素钙 |
26016-98-8 |
详细
|
| Linuron Impurity 6 |
秀草隆-D6 |
3408-97-7 |
详细
|
| Neratinib Impurity 25 |
来那替尼杂质25 |
2057445-26-6 |
详细
|
| Ritlecitinib Impurity 64 |
利特昔替尼杂质64 |
2411407-25-3 |
详细
|
| Enalapril Impurity 18 |
3-苯甲酰基丙烯酸乙酯 |
17450-56-5 |
详细
|
| Erlotinib Impurity 167 |
2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧基]乙醇 |
183321-86-0 |
详细
|
| Topiramate Impurity 41 |
托吡酯杂质41 |
106881-39-4 |
详细
|
| Fluindapyr Impurity 1 (Inpyrfluxam) |
吡咯烷酮 |
1352994-67-2 |
详细
|
| Fluindapyr Impurity 4 |
|
105113-52-8 |
详细
|
| Fluindapyr Impurity 5 |
|
141573-93-5 |
详细
|
| Empagliflozin Impurity 240 |
2-氯-5-碘苯甲酸甲酯 |
620621-48-9 |
详细
|
| Ritlecitinib Impurity 30 |
利特昔替尼杂质30 |
2042627-00-7 |
详细
|
| Irbesartan Impurity 40 Monomer |
1 氨基 环戊烷 氰基( 1-氨基-1-氰基 环戊烷)( 1-氨基-1-氰基 环戊烷) |
49830-37-7 |
详细
|
| Econazole Impurity 9 |
益康唑杂质 |
45892-47-5 |
详细
|
| Doxofylline Impurity 16 |
二乙二醇双对甲苯磺酸酯 |
7460-82-4 |
详细
|
| Doxofylline Impurity 14 |
多索茶碱杂质8 |
123524-29-8 |
详细
|
| Fluphenazine Dihydrochloride Impurity 10 |
|
76005-60-2 |
详细
|
| Ezetimibe Impurity 131 |
依泽替米贝杂质 |
1376615-01-8 |
详细
|
| Drotaverine Impurity 44 |
|
73530-02-6 |
详细
|
| Ascorbic Acid Impurity 34 |
糠偶酰 |
492-94-4 |
详细
|
| Ascorbic Acid Impurity 33 |
糠偶姻 |
552-86-3 |
详细
|
| Ascorbic Acid Impurity 32 |
2,5-DIHYDRO-FURAN-2-CARBOXYLIC ACID |
22694-55-9 |
详细
|
| L-Threonic Acid Monomer |
L-苏糖酸 |
7306-96-9 |
详细
|
| Fluphenazine Dihydrochloride Impurity 12 |
|
38483-89-5 |
详细
|
| Ritlecitinib-d3A |
|
2756700-89-5 |
详细
|
| Ritlecitinib-d2A |
|
2756700-96-4 |
详细
|
| Ritlecitinib Impurity 11 |
利特昔替尼杂质11 |
1792181-39-5 |
详细
|
| Ritlecitinib Impurity 18 |
利特昔替尼杂质18 |
2042627-18-7 |
详细
|
| Ritlecitinib Impurity 21 |
利特昔替尼杂质21 |
1792181-07-7 |
详细
|
| Ritlecitinib Impurity 24 |
利特昔替尼杂质24 |
1792182-42-3 |
详细
|
| Ritlecitinib Impurity 27 |
利特昔替尼杂质27 |
2411407-06-0 |
详细
|
| Ritlecitinib Impurity 28 |
利特昔替尼杂质28 |
2042627-12-1 |
详细
|
| Mirabegron Impurity 20 Hydrochloride |
(ALPHAR)-ALPHA-[[[2-(4-氨基苯基)乙基]氨基]甲基]苯甲醇盐酸盐 |
521284-22-0 |
详细
|
| Empagliflozin Impurity 234 |
恩格列净杂质82 |
154006-52-7 |
详细
|
| Ritlecitinib Impurity 14 |
利特昔替尼杂质14 |
1792180-91-6 |
详细
|
| Ritlecitinib Impurity 15 |
利特昔替尼杂质15 |
1792180-87-0 |
详细
|
| Clopidogrel Impurity 23 |
氯吡格雷杂质23 |
212838-70-5 |
详细
|
| Ritlecitinib-d2B |
|
2756700-93-1 |
详细
|
| Ritlecitinib-d1C |
|
2756700-95-3 |
详细
|
| Ritlecitinib-d1A |
|
2756700-88-4 |
详细
|
| Rasagiline Impurity 44 |
雷沙吉兰亚硝胺 |
2470278-90-9 |
详细
|
| Galactose Impurity 12 |
|
55637-63-3 |
详细
|
| Tartrazine Impurity 10 |
柠檬黄杂质6 |
104236-33-1 |
详细
|
| Neratinib Impurity 24 |
来那替尼杂质24 |
2749974-29-4 |
详细
|
| Bupropion Impurity 4 Monomer（Bupropion USP RC D Monomer） |
安非他酮杂质3 |
34509-36-9 |
详细
|
| Retagliptin mpurity 7 |
1598419-90-9 |
1598419-90-9 |
详细
|
| Retagliptin mpurity 8 |
1598419-91-0 |
1598419-91-0 |
详细
|
| Adagrasib Impurity 61 |
头孢唑肟杂质 |
1942004-69-4 |
详细
|
| Retagliptin mpurity 5 |
1598419-96-5 |
1598419-96-5 |
详细
|
| Retagliptin mpurity 3 |
瑞格列汀杂质3 |
1338939-60-8 |
详细
|
| Paclitaxel Impurity 88 |
氯甲酸-2,2,2-三氯乙酯 |
17341-93-4 |
详细
|
| Glycerol Impurity 137 |
9-十九烷醇 |
287389-99-5 |
详细
|
| Methadone Hydrochloride Impurity 20 |
DL-2-二甲氨基-1-丙醇 |
15521-18-3 |
详细
|
| Cholesterol Impurity 37 |
异丁酸酯 |
1180-43-4 |
详细
|
| Kanamycin A Sulfate |
硫酸卡那霉素 |
25389-94-0 |
详细
|
| Neratinib Impurity 23 |
来那替尼杂质23 |
2240142-43-0 |
详细
|
| Glycerol phenylbutyrate Impurity 10 |
|
114915-15-0 |
详细
|
| Neostigmine Impurity 19 |
新斯的明二聚体 |
63468-95-1 |
详细
|
| Ethyl Acetoacetate Impurity 12 |
乙基 2-溴-3-羰基丁酸酯 |
609-13-2 |
详细
|
| Sulfamic Acid Ammonium Salt |
氨基磺酸铵 |
7773-06-0 |
详细
|
| Diphenhydramine Impurity 18 |
苯海拉明柠檬酸盐 |
88637-37-0 |
详细
|
| Topiroxostat Impurity 81 |
4-吡啶甲亚胺酸甲酯 |
35451-46-8 |
详细
|
| Dopamine Impurity 86 |
3,4-二甲氧基-β-硝基苯乙烯 |
4230-93-7 |
详细
|
| Ritlecitinib Impurity 6 |
BENZYL (2S,5R)-5-AMINO-2-METHYLPIPERIDINE-1-CARBOXYLATE |
1207947-49-6 |
详细
|
| Beraprost Impurity 25 |
贝前列素杂质25 |
267898-36-2 |
详细
|
| Doxazosin Impurity 19 |
1,4-苯并二噁烷-2-甲酸甲酯 |
3663-79-4 |
详细
|